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ABSTRACT: A principal advantage of magic angle spinning (MAS) NMR
spectroscopy lies in its ability to determine molecular structure in a
noninvasive and quantitative manner. Accordingly, MAS should be widely
applicable to studies of the structure of active pharmaceutical ingredients
(API) and formulations. However, the low sensitivity encountered in
spectroscopy of natural abundance APIs present at low concentration has
limited the success of MAS experiments. Dynamic nuclear polarization
(DNP) enhances NMR sensitivity and can be used to circumvent this
problem provided that suitable paramagnetic polarizing agent can be
incorporated into the system without altering the integrity of solid dosages.
Here, we demonstrate that DNP polarizing agents can be added in situ
during the preparation of amorphous solid dispersions (ASDs) via spray
drying and hot-melt extrusion so that ASDs can be examined during drug
development. Speciﬁcally, the dependence of DNP enhancement on sample composition, radical concentration, relaxation
properties of the API and excipients, types of polarizing agents and proton density, has been thoroughly investigated. Optimal
enhancement values are obtained from ASDs containing 1% w/w radical concentration. Both polarizing agents TOTAPOL and
AMUPol provided reasonable enhancements. Partial deuteration of the excipient produced 3× higher enhancement values. With
these parameters, an ASD containing posaconazole and vinyl acetate yields a 32-fold enhancement which presumably results in a
reduction of NMR measurement time by ∼1000. This boost in signal intensity enables the full assignment of the natural
abundance pharmaceutical formulation through multidimensional correlation experiments.
■ INTRODUCTION
The stability, solubility, and bioavailability of active pharma-
ceutical ingredients (APIs) are key determining factors of
pharmaceutical formulation performance. Drug molecules can
undergo undesired phase transformations, such as amorphous
and crystalline interconversion, salt formation, and dispropor-
tionation induced by chemical, physical, and pharmaceutical
processes, transformations that often result in signiﬁcant
alterations in drug bioavailability. As a consequence analysis
by diﬀerential scanning calorimetry (DSC), thermogravimetric
analysis (TGA), powder X-ray diﬀraction (PXRD), Raman, and
mass spectrometry are routinely employed to monitor the
physicochemical properties of an API during drug formulation.
In addition to these techniques, magic angle spinning (MAS)
NMR can shed light on atomic scale molecular structures,
quantify various solid-state forms, and probe molecular
dynamics and chemical interactions in a nondestructive and
noninvasive manner.1−7 Although powerful, high throughput
measurements by MAS are limited due to the inherently low
sensitivity. Detection becomes even more challenging in
enabled formulations that contain small amounts of poorly
soluble API dispersed in a polymeric matrix for enhancing
bioavailability. Furthermore, MAS detection on nuclei other
than 1H suﬀers from both the low natural abundance and the
low gyromagnetic ratios of 13C and 15N when compared to 1H,
making it impractical to perform multidimensional correlation
experiments in a reasonable amount of time for exploration of
subtle molecular information.
The sensitivity of NMR can be improved by 2−3 orders of
magnitude8−14 by using dynamic nuclear polarization (DNP),
which transfers the high polarization of unpaired electrons to
nearby nuclei, such as 1H, 13C, and 15N via microwave
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irradiation of the electron−nuclear transitions. The maximum
theoretical enhancement factor is given by εmax= γe/γn = 658
where γe and γn are the gyromagnetic ratios of the electron and
nuclei, respectively. Thus, even a fraction of this translates into
a time saving of months or years, enabling many otherwise
infeasible experiments to be performed.15,16 The recent
developments of high-power microwave sources, NMR probes
for cryogenic MAS, biradical polarizing agents, and new sample
preparation methods, have enabled DNP to be successfully
applied to investigate the dynamics and structures of micro-
crystalline peptides, membrane proteins, amyloid ﬁbrils, natural
products, and catalytic materials.17−29
Recent studies have demonstrated the considerable potential
of DNP in applications to pharmaceutical chemistry.30−36 The
major challenge to successful DNP experiments lies in
developing a suitable method of introducing polarizing agents
into the sample for optimum signal enhancement without
sample disruption. A number of methods for preparing DNP
pharmaceutical samples have been reported, including polymer
ﬁlm casting and glass forming methods.34,37 In addition, Emsley
and co-workers have successfully demonstrated an innovative
impregnation method on the pharmaceutical formulations with
an organic solvent (1,1,2,2-tetrachloroethane) containing
polarizing agents.24 Enhancements in the range of 40−90
were obtained for commercial formulations containing cetirzine
dihydrochloride and excipients povidone, magnesium stearate,
hypromellose, and lactose. These enhancements allow rapid
characterization via one- and two-dimensional MAS spectra of
these formulations with drug loading <10%. Very interestingly,
molecular contacts between the API and povidone were evident
in the 1H−15N correlation spectra. However, the use of organic
solvents to dissolve radicals and impregnate formulations of
interest can result in perturbations of physical and chemical
properties of the components in a formulation. Indeed, in a
study of theophylline, the impregnation strategy has been found
to induce phase conversions that require further improvement
for broader application.36 Beyond this, the use of solvents
requires that polarizing agents have signiﬁcantly diﬀerent
solubility from other components in the formulation, which
limits the practical applications. Therefore, it is preferable to
avoid solvents when incorporating polarizing agents into the
sample.
The formulation of amorphous solid dispersions (ASDs) is
desirable since it enhances drug solubility and bioavailability.38
Therefore, there is a strong need for new tools to monitor and
study the chemical and physical stability during the formulation
development to ensure a stable product is delivered to the
clinic. DNP can play an essential role in enhancing the capacity
and eﬃciency of MAS NMR during early drug development
and provide information on the risks related to drug phase
changes in ASDs. Therefore, we have designed a protocol for
the preparation of DNP samples with the goals of (1)
introducing polarizing agents in a noninvasive manner to
maintain the integrity of the sample and (2) utilizing intensity
enhancement for rapid measurements to inform on formulation
development. Our strategy is to evaluate the in situ
incorporation of the polarizing agents during the processes of
spray drying (SD) and hot-melt extrusion (HME). These two
processes are widely applied for preparing ASDs in the
pharmaceutical industry. Brieﬂy, in SD, a solution containing
API, polymeric excipient, and free radicals, is sprayed against
the ﬂow of warm air that rapidly evaporates the solvent and
produces a dried powder. In HME, samples are made by
mechanically mixing the solid components at elevated temper-
atures, which creates an intimately combined melt of all the
components that is subsequently cooled and milled into a
powder.
In our proposed method for sample preparation, the radicals
are codissolved or comixed with formulation components for
SD and HME processes, respectively. In this report, a
clotrimazole-copovidone binary dispersion was used as a
model system to investigate the dependence of signal
enhancement on the following parameters: concentration and
type of polarizing agent, proton density, and ASD methods.
The optimized conditions were then adopted to prepare an
ASD composed of posaconazole and 2H-vinyl acetate, giving a
maximum DNP enhancement of 32. Our results also show no
observable structure perturbation or any phase conversion of
drug substance. We show that the large signal intensity increase
assists in the full assignment of posaconazole resonances from
two-dimensional homo- and heteronuclear correlation experi-
ments. To the best of our knowledge, this is the ﬁrst
documented DNP study investigating pharmaceutical formula-
tions prepared by spray drying and hot-melt extrusion.
■ EXPERIMENTAL SECTION
Materials. Molecular structures of the materials (API’s,
polymers, and biradical polarizing agents) used in our study are
shown in Figure 1. Copovidone Kollidon VA64, an amorphous
random copolymer of 1-viny-2-pyrrolidone and vinyl acetate
(60:40 mass ratio and 45−70 kDa molecular weight), was
obtained from BASF. Vinyl acetate (VA) was purchased from
Polymer Source, Inc. The API clotrimazole and posaconazole
were products of Spectrum Chemical Inc. and Merck Research
Laboratories (MRL), respectively. TOTAPOL39 and AMU-
Pol40 are biradical polarizing agents and were both evaluated to
enhance MAS NMR signal intensities. TOTAPOL was available
from Dynupol, Inc., and AMUPOL was a gift from and Dr.
Olivier Ouari and Prof. Paul Tordo (Aix-Marseille Universite)́.
Methanol (HPLC grade from Sigma-Aldrich) was used as a
solvent for the spray-drying process. All chemicals were used as
received.
Sample Preparation. Solid dispersions of all samples were
prepared by either spray drying or hot-melt extrusion (Figure
2). In both cases, a binary physical mixture of API and polymer
at a desired weight ratio was prepared by blending in a Turbula
mixer. The drug loading (API to polymer mass ratio) was 20%
in all preparations, except for the 1% (w/w) drug loading of
clotrimazole-copovidone ASD reported in the Supporting
Information (Figure S1), which showcases the capability of
DNP to detect very weak signals. Typically, ∼ 100 g of the
mixture was sealed in a 500 mL glass bottle and blended for 1 h
at room temperature. The mixture then underwent spray drying
or hot-melt extrusion processes as described below. Pure API
and polymer samples were made with the same protocol.
Spray drying was conducted on a ProCepT 4M8-TriX
Formatrix spray dryer equipped with a 0.6 mm biﬂuid nozzle.
First, a solution of polymer and API in methanol (∼20−40 mg/
mL) with the desired amount of radical (0−2% weight ratio in
the dried product) was prepared. The solution was then
sprayed against a stream of air ﬂowing at 0.4 m3/min. The
solution was fed into the atomizing nozzle at a rate of 5 mL/
min and atomized using compressed air at 70 psi. The inlet and
outlet temperatures were 353 and 323 K, respectively. The
dried powders were collected and stored at room temperature
in 10 mL amber glass bottles in a desiccator.
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Hot-melt extrusion (HME) was performed with a custom-
ized micro twin screw extruder (MP&R Model ME7.5)
equipped with corotating conveying screws which have a
diameter and length/diameter ratio (L/D) of 7.5 mm and 15:1,
respectively.41,42 In a typical process, ∼ 3 g of the blended
binary physical mixture at a desired radical content were fed
into the extruder by a vibratory feeder. The barrel temperature
was set at 418 K and the screw frequency was 100 rpm. The
hot-melt extrudates were collected, allowed to cool, milled into
powder via a benchtop mill (Polymix PX-MFC 90 D), and
stored in a desiccator at room temperature.
DNP/NMR Experiments. In order to assess the optimum
sample condition, 1H−13C/15N cross-polarization (CP) experi-
ments were performed on a home-built DNP/NMR instrument
operating at 250 GHz/380 MHz with ∼14 W of microwave
power.43,44 Spectra were recorded using a triple resonance (1H,
13C, and 15N) cryogenic MAS probe equipped with a sample
exchange system45 on a home-built NMR spectrometer
operating at 9 T at T = 85 K. Approximately 45 mg of each
powder sample was packed into a 4 mm sapphire rotor. The
spinning frequency is ωr/2π = 5.5 kHz unless stated otherwise.
ω1H/2π = 50 kHz was employed during CP and a TPPM
decoupling ﬁeld ω1H/2π = 100 kHz was used during
acquisition. T1H was measured using saturation recovery
sequence (Figure S2). Enhancement factors (ε) were calculated
by comparing the signals obtained with and without microwave
irradiation.
Further characterization by 2D correlation MAS was carried
out on a 263 GHz/400 MHz system (consisting of an Avance
III HD console, Ascend 9.4 T NMR magnet, and 263 GHz
gyrotron) and a 395 GHz/600 MHz system (Avance III HD
console, Ascend Aeon 14.1 T magnet, and 395 GHz gyrotron).
The microwave power at the sample was ∼10 W on both
systems. Approximately 20 mg of each powder sample was
packed into 3.2 mm sapphire rotors. At 400 and 600 MHz, ωr/
2π = 9 kHz and 12.5 kHz, respectively. Two kinds of 2D NMR
experiments were performed, including 13C−13C refocused
INADEQUATE (incredible natural abundance double quan-
tum transfer experiment) of clotrimazole and 1H−13C and
1H−15N HETCOR (heteronuclear correlation) of posacona-
zole. The refocused INADEQUATE spectra were acquired with
a recycle delay of 2 s, 80 t1 increments, and 384 scans per
increment, for a total experiment time of ∼17 h. The HETCOR
spectra of posaconazole were acquired with a recycle delay of 3
s, 64 t1 increments, and 256 scans per increment, for a total
experiment time of approximately 14 h. Both short and long
contact time (0.45 and 1.5 ms, respectively) HETCOR spectra
were acquired to assist with assignments. The sample
Figure 1. (A) Chemical structures of the two APIs clotrimazole and
posaconazole, (B) the polymeric excipients copovidone (n:m = 1:2)
and vinyl acetate, and (C) the biradical polarizing agents TOTAPOL
and AMUPol. All atoms in clotrimazole and posaconazole are labeled
for NMR resonance assignments in the subsequent DNP-enhanced
experiments.
Figure 2. Schematic of amorphous solid dispersions (ASD) sample
preparations. Polarizing agents are mixed with the API and polymer
molecules in a wet or dry process of spray drying or hot-melt
extrusion, respectively. After producing the ASD, the powders can be
directly packed for solid-state characterization by DNP-enhanced MAS
NMR.
The Journal of Physical Chemistry B Article
DOI: 10.1021/acs.jpcb.7b07213
J. Phys. Chem. B XXXX, XXX, XXX−XXX
C
temperature during these experiments was 99 ± 2 K, as
calibrated using KBr.46 2D spectra were processed with zero-
ﬁlling to double the size and a Gaussian window function
centered at 0.1 and 50 Hz of broadening, in both the direct and
indirect dimensions. Quadrature detection in the indirect
dimension was accomplished using the States-TPPI scheme. All
DNP/NMR pulse sequences are included in Figure S2.
■ RESULTS AND DISCUSSION
Polarizing Agent Concentration. The enhancement and
1H relaxation properties of spray-dried samples with increasing
concentrations of TOTAPOL (0, 0.5, 0.75, 1, and 2%, w/w)
were measured and are shown in Figure 3. Three diﬀerent
sample compositions were used, including pure API clotrima-
zole (Figure 3A), pure polymer copovidone (Figure 3B), and a
clotrimazole/copovidone binary formulation (Figure 3C). We
found that for samples containing clotrimazole (Figure 3A and
C), the optimal radical concentration was 1%. We note that
both SD and HME involve elevated temperatures especially
HME (418 K, vide supra), which can potentially lead to
thermal degradation of nitroxide radicals. However, the TGA
analysis (data not shown) showed that TOTAPOL and
AMUPol did not undergo thermal degradation until temper-
atures of 516 and 526 K, respectively, which is signiﬁcantly
higher than the processing conditions. Furthermore, EPR
spectra (Figure S3) share the same characteristics as the
published data suggesting that the nitroxides remained intact
through the SD and HME processes.47 EPR spectra also
showed no sign of radical aggregation. To evaluate the
possibilities of sample perturbations induced by the addition
of radicals, we have compared ASDs with and without
TOTAPOL using ssNMR and PXRD, shown respectively in
Figures S4 and S5. No chemical shift change is observed in the
13C NMR spectra and the X-ray powder pattern also conﬁrms
the amorphous nature of the ASDS, suggesting no amorphous
to crystalline conversion.
Note also that, to date, DNP applications usually involve
solutions of polarizing agents and require 5−10 mM of
biradical.8 The optimum concentration in our method is 2−3
times higher, with 1% weight ratio corresponding to roughly 20
mM of biradical. This may be due to the spatial distribution of
the radical in the solid state, where not all radicals are in close
proximity to the polymer and/or API.
In Figure 3B, the enhancement of copovidone signal
monotonically increased with increasing TOTAPOL and did
not saturate at 2% TOTAPOL concentration. We attribute this
to polymer motions and hence, the very short T1 (1.6 s) of
1H
in copovidone in the absence of radical. In comparison, pure
clotrimazole has much longer T1 (24 s). However, both
components in the clotrimazole/copovidone mixture exhibit
essentially the same proton T1 of ∼3.5 s (Figure 3C),
suggesting a good miscibility of the components, which is an
indicator of stable pharmaceutical formulations.48 The mis-
cibility is further supported by the fact that the DNP
enhancement is uniform throughout the samples regardless of
the radical concentration. A good miscibility in a solid-state
mixture is required for eﬃcient 1H−1H spin diﬀusion, which in
turn results in a uniform T1 and DNP enhancement. Thus, the
DNP enhancement may be a useful indicator of the miscibility
of pharmaceutical formulations. Both the enhancement and T1
values of the combined dispersion are roughly equal to the
weighted arithmetic average of the two individual components,
indicating that the nitroxide is evenly distributed among both
members.
An optimum radical concentration is determined based on
several parameters. On one hand, higher polarizing agent
concentrations provide a denser electron pool, which leads to
higher enhancement values. On the other hand, the electrons in
the nitroxides are paramagnetic species and lead to para-
magnetic relaxation enhancement (PRE) eﬀect. This eﬀect
shortens the spin−lattice (T1) and spin−spin relaxation (T2)
times of nearby nuclei. As a consequence, the PRE eﬀect on T2
leads to line broadening, loss of resolution and the inability to
acquire multidimensional NMR experiments that require T2 for
polarization transfer.45,49 Therefore, the optimal polarizing
agent concentration is a balance of maximizing electron to
proton polarization transfer while minimizing PRE eﬀects.
Proton Density. We have investigated the impact of proton
density by comparing spray dried intermediates containing
either protonated or deuterated vinyl acetate (VA). Both
samples were loaded with 20% API clotrimazole and 1%
TOTAPOL. Deuterated VA resulted in a greater than 3-fold
improvement in the DNP enhancement (12 vs 3.6, Figure 4A),
similar to the result found previously in other sample
preparation methods.50−52 In experiments based on CP and
detection on low gamma nuclei, such as 13C or 15N, the beneﬁt
of diluting 1H in the solvent is 2-fold. First, it reduces the ratio
between the populations of protons and electrons. Second,
diluting the 1H bath lengthens the intrinsic proton T1 of an
Figure 3. Dependence of DNP enhancement and spin−lattice
relaxation property on radical concentration for clotrimazole (A),
copovidone (B), and spray dried clotrimazole-copovidone ASD (C).
Enhancement and T1 measurements are shown in the left and right
columns, respectively.
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undoped sample by attenuating 1H−1H dipole interactions
and/or dynamics. The remaining 1H concentration is suﬃcient
to disperse the electron polarization via spin diﬀusion and
transferring that polarization to 13C or 15N via CP. Previous
work from Griﬃn’s group has established glass-forming matrix
containing glycerol-d8/D2O/H2O (60/30/10, v/v) as a solvent
of choice to form a frozen glassy matrix at T < 220 K, and it is
used in the majority of DNP biological applications.50,53
Subsequent studies have explored the use of organic solvents
for applications involving insoluble materials; nevertheless, a
deuteration level of ∼90% remains standard.49,54−57 In
addition, Akbey et al. obtained a 3−5 fold larger enhancement
using perdeuterated then back exchanged SH3 protein instead
of protonated samples.52
In Figure 4B−D, we study the eﬀect of deuteration on
polarization transfer processes during DNP and CP. The pulse
sequence for measuring these polarization dynamics is shown in
Figure 4B. After saturation (sat) irradiation, the magnetization
of protons is enhanced by DNP and then transferred to 13C via
CP for detection. DNP buildup curves in Figure 4C showed
that the polarization for the protonated vinyl acetate containing
sample reached equilibrium at ∼4 s, much faster than that for
the deuterated one (∼12 s). This is as expected since
protonated polymer has denser 1H matrix for more eﬃcient
spin diﬀusion. As shown in Figure 4D, we observed essentially
the same CP buildup curve for the signals from the clotrimazole
(left curves in D), whereas signals of protonated and deuterated
VA displayed diﬀerent CP dynamics (right curves in D).
Deuterated VA required signiﬁcantly longer CP contact time (8
ms vs 3 ms) which strongly suggests intermolecular CP from
1H of the API to the 13C of the deuterated polymer. Previously,
such information was obtained via 1H−1H and 19F−1H spin
diﬀusion between API and polymer in formulations.2 Our result
opens up a new possibility of obtaining intermolecular contact
between API and polymer in pharmaceutical formulations using
deuterated polymer excipients.
Hot-Melt Extrusion vs Spray Drying. With the full
optimization of DNP enhancement for ASDs prepared via SD,
our next goal is to investigate the enhancement performance on
dispersions prepared by diﬀerent techniques. Of particular
interest is HME, a low-cost and environmentally friendly
method developed over the last three decades for preparing
polymer-based ASDs of low solubility drugs. Diﬀerent from the
SD process, where the radical-containing ASD is produced by
rapidly evaporating the volatile methanol solvent into hot air
and has the advantage of a lower processing temperature which
minimizes the thermal degradation of nitroxide radicals, the
HME process involves mechanically mixing various ingredients
at an elevated processing temperature, thus requiring no solvent
and no speciﬁc solubility of API, polymer or DNP radical.
Figure 5 compares the DNP enhancement and T1 relaxation
of clotrimazole/copovidone ASDs produced by HME and SD,
each with various TOTAPOL concentrations. The HME curve
shows that the enhancement reaches a maximum at 0.5% (w/
w) radical concentration and remains saturated as the radical
concentration is increased, presumably allowing for a greater
range of optimal radical concentration than the SD method.
Nevertheless, Figure 5B shows that both of these enabled
formulation methods yield comparable DNP performances, ε =
5 for clotrimazole/copovidone ASD with 1% TOTAPOL.
HME T1H measurement exhibits a slightly weaker PRE eﬀect
on the relaxation at a higher nitroxide concentration in Figure
5C. Due to slower molecular motions at the colder temper-
atures, T1H values are roughly 4 times longer at cryogenic
temperature than at ambient temperatures as shown in Figure
5D. With 1% TOTAPOL (w/w), the T1 values are
approximately 1 s at 107 K for both HME and SD (as
reported in Figure 3). The absolute value of T1 is an indicator
of factors, such as particle size, humidity, API-polymer
interaction resulting from the dispersion processes as well as
the PRE eﬀect. The fact that diﬀerent processes are suitable for
in situ DNP sample preparation diversiﬁes the collection of
pharmaceutical compounds and formulations accessible by our
Figure 4. (A) Enhancement spectra of clotrimazole-vinyl solid dispersion samples: 1H vinyl acetate (left) and 2H vinyl acetate (right). (B) Pulse
sequence for measuring the dependence of polarization transfer on DNP buildup time, tDNP and CP contact time, τCP. Build-up curves of DNP (C)
and CP (D) for 1H vinyl acetate (blue) and 2H vinyl acetate (red) containing dispersions. In (C), API and polymer exhibit identical tDNP. In (D), CP
buildup curves for API and polymer are shown on the left and right, respectively. All data were obtained using 50 kHz of proton spin lock during CP
and 100 kHz 1H dipolar decoupling during acquisition at 380 MHz.
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approach. Overall, the two ASD methods yielded similar DNP
performances, suggesting the forgiving nature of introducing
polarizing agents in wet and dry manners. Furthermore, it
permits selection of the method based on its advantages.
Enabling Multidimensional MAS NMR Spectroscopy
for Analyzing Pharmaceutical Formulation. In the
previous sections, DNP enhancements of various clotrimazole
samples conditions were investigated, including the concen-
tration and types of polarizing agents, proton density, and
dispersion techniques. In this section, we present DNP/NMR
structural investigations of the samples prepared by the enabled
formulation methods. To this end, we ﬁrst further improved the
DNP enhancement by using AMUPol instead of TOTAPOL as
the polarizing agent. Figure 6 shows the 13C spectrum of
clotrimazole doped with 1% TOTAPOL and 13C, 15N of the
same API doped with 1% AMUPol taken at 380 MHz. The
enhancement with AMUPol was 17, which roughly doubled
that obtained with TOTAPOL. Our result is in good agreement
with previous studies that established AMUPol as the radical of
choice for DNP applications at ∼100 K.10,40,58 The superior
performance of AMUPol facilitates the detection of low natural
abundance and low gamma nuclei, such as 15N. In the 1D
1H−15N CP of Figure 6, both nitrogen atoms on the imidazole
group can be assigned. The doubling of N1 and broadening of
N2 suggest that the molecules may adopt two diﬀerent
amorphous forms.59
The large improvement in the sensitivity facilitates 2D
13C−13C homonuclear correlation experiments as shown in
Figure 7. The homonuclear 13C−13C spectrum of clotrimazole
was acquired using refocused-INADEQUATE, a pulse
sequence establishing 13C−13C correlations from magnetization
transfer through J-couplings.24,33,60,61 In Figure 7, correlations
of C4 with C1, C5, C8 are identiﬁed based on previous
assignments. The contacts between aromatic carbons are shown
in the full 2D refocused-INADEQUATE in Figure S6. The
optimized parameters provide a successful example of
investigating intramolecular carbon−carbon correlations of
natural abundant drugs using DNP-enhanced MAS NMR.
These optimized sample conditions (vide supra) were also
applied to the study of the commercialized drug posaconazole,
which is a triazole antifungal drug (trade name Noxaﬁl).62,63 An
ASD containing the API posaconazole and polymeric excipient
2H-vinyl acetate with 1% AMUPol was prepared via spray
drying. The DNP-enhanced 13C spectra are shown in Figure 8.
An enhancement of 25 was obtained for the posaconazole ASD,
determined from the microwave-on and -oﬀ spectra spinning at
Figure 5. (A) DNP enhancement of extruded clotrimazole/
copovidone dispersion with varying (w/w) concentrations of
TOTAPOL. (B) Similar enhancement of clotrimazole-copovidone
with 1% TOTAPOL prepared via SD and HME. (C) T1 of the HME
samples, measured using a saturated recycle delay value with HC
1H-13C CP experiments with 50 kHz of proton spin lock during CP
and 100 kHz 1H decoupling during acquisition at 380 MHz, 90 K. (D)
Room temperature (blue) and low temperature (red) T1 values of
clotrimazole-copovidone with 1% TOTAPOL prepared by SD and
HME.
Figure 6. DNP enhanced natural-abundance 13C and 15N CP-MAS
spectra showing enhancements of (A) clotrimazole doped with 1%
TOTAPOL and at 90 K and (B) 1% AMUPol at 104 K.
Enhancements are 10 and 17 at 380 MHz, respectively. The 13C
spectra were acquired with 8 scans, recycle delay of 4 s, and the 15N
spectrum was collected with recycle delay of 3 s and 8k scans.
Figure 7. 2D 13C−13C refocused INADEQUATE spectrum of
clotrimazole showing intramolecular contacts among 13C resonances
as marked in the molecular structure on the right. The full spectrum is
included in the Figure S4. The 2D spectrum was acquired in 17 h at
106 K on 400 MHz, 384 scans per increment, 2 s recycle delay, and 80
t1 increments of a 27.7 us.
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9 kHz in Figure 8A. Previous studies have suggested the
enhancement dependence on MAS frequencies.10,64,65 Further
optimization exhibited a maximum enhancement of 32 at ωr/2π
= 5 kHz, as shown in Figure S7. Compared to clotrimazole/2H-
vinyl acetate, higher DNP enhancement was achieved for
posaconazole/2H-vinyl acetate ASD, likely due to diﬀering
molecular interactions and packings between radicals and APIs.
Deuteration of the polymer not only improves the enhance-
ment by a factor of 3−4, but also simpliﬁes the analysis of API
signals by suppressing signals originated from the polymer. The
15N spectrum in Figure 8B was acquired in 1 h, while without
DNP enhancement, it would have taken almost a month to
achieve the comparable sensitivity for the same amount of
samples. All eight 15N atoms in the drug molecule can be seen
and tentatively assigned according to previous publications.63
To complete the resonance assignments and establish the
intramolecular correlations, 2D heteronuclear experiments were
conducted as illustrated in Figure 9.
Pharmaceutical solids are often disordered and multi-
component systems, leading to low resolution in spectroscopic
investigations. To obtain unambiguous and high-resolution
information for structural elucidations, it is best to use 2D MAS
NMR techniques to establish intra- and intermolecular
correlations. However, multidimensional correlation becomes
extremely challenging and often practically infeasible for low-γ
spins, such as 13C and 15N rich drug molecules. DNP-enhanced
13C- and 15N-detected correlation experiments were performed
as shown in Figure 9A and B, respectively. Taking 2D 13C−1H
HETCOR in Figure 9A, for example, the spectra were collected
with 0.4 ms contact times for correlations of short distances and
1.5 ms for long distances. In the 1H dimension, three types of
functional groups including aliphatic, aromatic-N, and aromatic
protons can be assigned. At the short mixing time (blue), the
cross peaks between adjacent protons and carbon are observed,
e.g., cross peaks between C3, 4, 30, 31 and aliphatic protons;
C18, 19 and aromatic protons. Giving a longer spin diﬀusion
transfer (red), 13C−1H cross peaks of those at a farther distance
appear, e.g., aliphatic C27 and aromatic protons. Distance
information is encoded in these correlations at short and long
diﬀusion times, facilitating the assignments of most carbons.62
2D 1H−15N HETCOR spectra were also acquired at short
(0.45 ms) and long (1.5 ms) mixing times (Figure 9B). Cross
peaks are observed between all eight nitrogen atoms and their
neighboring protons including aliphatic, aromatic, and amide
protons. Given the fact that 15N has lower γ (−4.316 MHz/T)
and natural abundance (0.368%) among the spins of interest in
pharmaceutical molecules, it is worth emphasizing the success
of acquiring these 2D spectra in 7 h, a reasonably short period
of time for practical analysis. These results have shown DNP as
a powerful technique for enhancing ssNMR signal intensities
for investigating structures and probing interactions of natural
abundance drugs and formulations.
■ CONCLUSION
In summary, our study has served as the ﬁrst documented
example of an in situ preparation of DNP samples to support
structural investigations of practical formulation processes.
Polarizing radicals have been successfully incorporated during
routine pharmaceutical production of solid dispersions
including SD and HME. The DNP enhancement has been
optimized by investigating the sample and its relaxation
parameters. Partial deuteration of ASDs results in more than
a 3-fold increase in enhancement value. An optimum
Figure 8. DNP-enhanced (A) 13C and (B) 15N CP-MAS spectra of
natural abundance posaconazole-deuterated vinyl acetate ASD. Both
experiments were conducted with ωr/2π = 9 kHz. The enhancement
value dependence on spinning frequency is presented in Figure S5.
The 13C spectrum was recorded with 128 scans, recycle delay of 10 s.
The 15N spectrum was acquired with 1024 scans, recycle delay of 4 s.
Figure 9. 2D DNP-enabled heteronuclear correlation spectra of
natural abundance posaconazole-2H vinyl acetate ASD: (A) 13C−1H
and (B) 15N−1H spectra with short and long mixing times. HETCOR
pulse sequence is shown in Figure S2. Each HETCOR experiment was
acquired in 7 h at 106 K with 3 s recycle delay, 64 t1 increments, and
256 scans per increment at ωr/2π = 9 kHz. The
13C−1H and 15N−1H
HETCOR spectra were acquired with FSLG homonuclear decoupling
at 400 and 600 MHz, respectively.
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enhancement of 20−30 was obtained and enables detection of
low drug loading (i.e., 1%) formulations and the 2D
homonuclear 13C−13C and heteronuclear 13C−1H and
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